AXDX stock forecast
Our latest prediction for Accelerate Diagnostics Inc's stock price was made on the Aug. 25, 2022 when the stock price was at 1.70$.
In the short term (2weeks), AXDX's stock price should underperform the market by -1.12%. During that period the price should oscillate between -11.12% and +14.22%.
In the medium term (3months), AXDX's stock price should underperform the market by -7.84%. During that period the price should oscillate between -24.30% and +20.85%.
Get email alertsCreate a solid portfolio with AXDX
About Accelerate Diagnostics Inc
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichemâ„¢ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
At the moment the company generates 8M USD in revenues.
On its last earning announcement, the company reported a loss of -0.80$ per share.
The book value per share is 1.75$
Three months stock forecastAug. 25, 2022
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
8M | 33.80% | -51M | -592.81% | -53M | -0.80 | - | - | 79M | 1.75 | - | - | - |